(login)

Vertically integrated pharmaceutical
company in the Baltic States

Stock news


2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
Notification on convocation of joint stock company GRINDEKS Annual General Meeting of shareholders and DRAFT RESOLUTIONS
11.05.2015

Read more


JSC «Grindeks» audited financial results for twelve months of 2014
30.04.2015

Read more


JSC «Grindeks» unaudited interim report for 12 months of 2014
27.02.2015

Today, on 27 February, the JSC «Grindeks» submitted the non-audited consolidated financial statements for twelve months of 2014 to “NASDAQ Riga”. Non-audited financial results indicate that the Group closed 2014 with a net loss of 2.3 million euros related to the shareholders of the holding company. In comparison the Group’s net profit in 2013 was 13.5 million euros. The Group’s turnover amounted to 88.4 million euros in 2014, which is by 30 million euros or 25% less than in 2013. In 2014, gross profit margin of the Group was 54%, whereas, net profit margin was -2.6%. Products of the Group, manufactured in 2014, were exported to 60 countries worldwide for the total amount of 83 million euros, which is by 29.3 million euros or by 26% less than in 2013. The geopolitical situation in Russia and Ukraine is the key factor affecting Group performance indicators. Most of the Group financial losses are related to the dramatic decline in the value of Russian ruble – consequently, foregone earnings of the Group makes at least 6.2 million euros.

Read more


Juris Bundulis has been reelected as the Chairman of the Board of JSC “«Grindeks»” for another term of the office
09.01.2015

Read more


RESOLUTION of the Extraordinary General Meeting of Shareholders of joint stock company «Grindeks» held on 22 December 2014
22.12.2014

Read more